title: TCR engagement in the absence of cell cycle progression leads to T cell anergy independent of p27(Kip1).
abstract: We have proposed a model in which the prevention of anergy by costimulation is the result of IL-2-induced G1 to S phase cell cycle progression. Here we demonstrate that the reversal of anergy by exogenous IL-2 also occurs during this window of the cell cycle. Recently, it has been proposed that the cell cycle inhibitor p27(Kip1) is an anergic factor. In contrast, our data demonstrate that during the induction, maintenance and rechallenge phases of anergy, p27(Kip1) levels do not correlate with the anergic phenotype. Although p27(Kip1) levels were down-regulated by IL-2 during the G1 to S phase transition, the amount of IL-2 required to produce this effect was far lower than that required to prevent the induction of anergy. Furthermore, T cell lines from p27(Kip1) knockout mice were anergized as well as T cells from mice that were heterozygous for p27(Kip1). Interestingly, the forced overexpression of p27(Kip1) was able to decrease IL-2 promoter-induced transcription, suggesting that the cell cycle machinery may be involved in T cell activation; however, physiological levels of p27(Kip1) did not prevent IL-2 transcription. Overall, our data serve to disassociate the ability of IL-2 to down-regulate p27(Kip1) and its ability to prevent or reverse anergy.
authors.affiliation: Laboratory of Cellular and Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-0420, USA.
authors.forename: J D
authors.initials: JD
authors.lastname: Powell
authors.forename: D
authors.initials: D
authors.lastname: Bruniquel
authors.forename: R H
authors.initials: RH
authors.lastname: Schwartz
mesh_terms: D000818:Animals; D002453:Cell Cycle; D018797:Cell Cycle Proteins / Q000502:physiology*; D002460:Cell Line; D050760:Cyclin-Dependent Kinase Inhibitor p27; D015536:Down-Regulation; D005786:Gene Expression Regulation; D007108:Immune Tolerance; D007376:Interleukin-2 / Q000235:genetics / Q000494:pharmacology; D051379:Mice; D018345:Mice, Knockout; D011494:Protein Kinases / Q000502:physiology; D012333:RNA, Messenger / Q000032:analysis; D011948:Receptors, Antigen, T-Cell / Q000502:physiology*; D013601:T-Lymphocytes / Q000276:immunology*; D058570:TOR Serine-Threonine Kinases; D025521:Tumor Suppressor Proteins / Q000502:physiology*
chemical_list: C493961:Cdkn1b protein, mouse; D018797:Cell Cycle Proteins; D007376:Interleukin-2; D012333:RNA, Messenger; D011948:Receptors, Antigen, T-Cell; D025521:Tumor Suppressor Proteins; D050760:Cyclin-Dependent Kinase Inhibitor p27; D011494:Protein Kinases; C546843:mTOR protein, mouse; D058570:TOR Serine-Threonine Kinases